Aandelen in “Productie van wapens en munitie”

Aandeel	Datum	Koers	Evolutie
Inovio Pharmaceuticals Inc	30/12	1,760 USD +1,73%	+1,73%

Nieuws over “Productie van wapens en munitie”

Toon enkel gratis nieuws

29/12 · FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) · Persbericht

29/12 · FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) · Persbericht

19/12 · INOVIO Reports Inducement Grant Under Inducement Plan · Persbericht

18/11 · INOVIO to Participate in December Investor Conferences · Persbericht

11/11 · INOVIO Announces Pricing of $25 Million Public Offering · Persbericht

11/11 · INOVIO Announces Proposed Public Offering · Persbericht

10/11 · INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights · Persbericht

3/11 · INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults · Persbericht

31/10 · INOVIO Reports Inducement Grant Under Inducement Plan · Persbericht

27/10 · INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 · Persbericht

23/10 · INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference · Persbericht

21/10 · Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine · Persbericht

2/10 · INOVIO Reports Inducement Grant Under Inducement Plan · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe